Bandingkan Harga & Kinerja Fortune Mate Indonesia Tbk (FMII) vs Brigit Biofarmaka Teknologi Tbk. (OBAT)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Fortune Mate Indonesia Tbk dan Brigit Biofarmaka Teknologi Tbk.: Fortune Mate Indonesia Tbk diperdagangkan di Rp252 (kapitalisasi pasar 1,59 T, volume 24 jam 142,4 rb), sedangkan Brigit Biofarmaka Teknologi Tbk. diperdagangkan di Rp246 (kapitalisasi pasar 167,37 M, volume 24 jam 71 rb). Perbedaan utamanya: Fortune Mate Indonesia Tbk jauh lebih besar — sekitar 9,5× kapitalisasi pasar Brigit Biofarmaka Teknologi Tbk., dan Fortune Mate Indonesia Tbk lebih aktif diperdagangkan (142,4 rb vs 71 rb). Mana yang lebih baik tergantung tujuan investasimu.
| FMII | OBAT | |
|---|---|---|
Kapitalisasi Pasar | 1,59 T | 167,37 M |
Volume | 142,4 rb | 71 rb |
Lot | 1,42 rb | 710 |
Perputaran | 35,31 jt | 17,51 jt |
Harga Rata-rata | 247,99 | 246,63 |
Nilai Transaksi | 35,31 jt | 17,51 jt |
Harga Ekuilibrium Indikatif | 252 | 246 |
Volume Ekuilibrium Indikatif | 33 | 1 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Fortune Mate Indonesia Tbk
PT Fortune Mate Indonesia Tbk (the Entity) was established within the framework of the Foreign Capital Investment Law (PMA) No. 1 year 1967 based on Notarial Deed No. 44 dated June 24, 1989 by Rika You Soo Shin, S.H., notary in Surabaya. The Entity has started its commercial operations since 1989 comprises the manufacturing of footwear were located in Sidoarjo, East Java and stopped its operation since middle of March 2004. The Entity's office and real estate are located in Surabaya.
Selengkapnya di halaman FMII →Tentang Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Selengkapnya di halaman OBAT →
